Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 October 2024 | Story Litha Banjatwa | Photo Supplied
Matriculant of the year 2024
This year’s winner, Jayden Leech (centre), deputy head boy and hockey captain at Grey College.

For more than four decades, the University of the Free State (UFS) has used its annual Matriculant of the Year competition to attract the country’s top matriculants. This prestigious award recognises and celebrates the exceptional achievements of South African high school students who excel in academics, sports, culture, and leadership.

This year’s winner, Jayden Leech, deputy head boy and hockey captain at Grey College, stands out not only for his academic average of 90% but also for his sporting achievements. He has represented South Africa in karate and has been a member of the Free State Hockey and Waterpolo teams for the past three years. Jayden has been selected to pursue a medical degree.

The competition is closely aligned with the UFS’s Vision 130, which envisions a future where academic excellence, innovation, and societal impact are prioritised. “By recognising academic success, creativity, resilience, and leadership potential, the university aims to attract the brightest minds to join its community. This competition serves as a platform to identify and nurture future leaders who will help address South Africa's pressing challenges,” says Nomonde Mbadi, Director of Student Recruitment Services.

This year, the competition attracted 60 applicants, with a strong representation of women - 43 women and 17 men. The Free State province led with 28 entries, followed by North West, KwaZulu-Natal, and Gauteng. Popular fields of study among applicants included Medicine (MBChB), Accounting, Engineering, and Law. While the overall academic average of all entries was an impressive 81%, the top 14 finalists achieved an outstanding average of 85%.

Through a series of interviews and group activities, candidates were assessed on their critical thinking, communication skills, and ability to collaborate effectively. The Matriculant of the Year is ultimately selected for their overall balance, leadership potential, and capacity to serve as an ambassador for the UFS.

The Matriculant of the Year competition reflects the UFS’s commitment to fostering a diverse, inclusive, and equitable learning environment, aligned with the university’s values of social justice and sustainability. “By aligning this competition with Vision 130, we reaffirm the UFS’s dedication to transforming lives, creating opportunities, and shaping the next generation of leaders who will drive societal and economic progress,’’ adds Mbadi. 

News Archive

UFS cardiac team leading with project
2017-05-31

 Description: Cardiac team read more Tags: Cardiac team read more

Prof Peter Schultheiss of the Charité University in Berlin,
Germany, visited the Robert WM Frater Centre for
Cardiovascular Research at the UFS for a study regarding
cardiomyopathy, a significant cause of fatal heart failure
among Africans. From the left are Dr Glen Taylor,
Dr Danie Buys, Prof Makoali Makatoko,
Prof Schultheiss and Prof Francis Smit.
Photo: Rulanzen Martin

A team of cardiac doctors associated with the Robert WM Frater Cardiovascular Research Centre at the University of the Free State’s (UFS) Faculty of Health Sciences has commenced with a pioneering research project regarding idiopathic dilating cardiomyopathy.  

An Afrocentric research focus
Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS and Head of the Frater Centre, describes dilating cardiomyopathy as a heart muscle disease that is quite common, particularly among people of African descent. The disease weakens the heart muscle, which in turn leads to heart failure.

“To date there is no curable treatment for this condition and 50% of patients that have shown heart failure, died within a period of five years. The causes of this condition have been unknown in the majority of patients. But over the past few years major strides have been made where virus infections of the heart muscle or myocarditis have been identified as a possible underlying cause. Various genetic diseases are also linked to it,” says Prof Smit.

International collaborations ensure success
According to Prof Smit, the project is being run in conjunction with Prof Heinz-Peter Schultheiss of the Charité University and the Institute for Cardiac Diagnostics and Therapy in Berlin, Germany.

“We have been working on the project over the past 18 months and I have twice visited Prof Schultheiss in Germany. He is now visiting us in Bloemfontein. We have established a collaborative project focused on patients in central South Africa”.
Prof Schultheiss is a world leader regarding the diagnosis, pathology and treatment of dilating cardiomyopathy, says Prof Smit.

“He brings a lifetime of research experience to Bloemfontein and is internationally renowned as the father of myocardial or heart muscle biopsies.

“His pioneering work on the discipline has led to diagnostic accuracy that has induced purposeful and personalised treatment of dilating cardiomyopathy and has brought about dramatic changes in some subsets of patients’ life expectancy and their cure.”

Solving problems close to home
According to Prof Mokoali Makatoko, Head of the Department of Cardiology, there are more than 1500 new cases of heart failure identified annually at the Universitas Academic Hospital, of which approximately 30% are attributed to cardiomyopathy. “With the use of endomyocardial biopsies the team hopes to treat viruses unique to Southern Africa as well as other underlying causes of dilating cardiomyopathy.”

Prof Stephen Brown, Head of Paediatric Cardiology at the Universitas Academic Hospital, says children suffering from this disease never reach a mature age and those under his supervision will also be undergoing these tests. Various other departments at the UFS will also participate in this project. Profs Makatoko and Brown did the first four endomyocardial biopsies under the management of Prof Schultheiss during the past week. The results will be available in the coming weeks after which the project will be officially launched and patient recruitment will start in earnest.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept